Among the topics covered in this Respiratory News Live broadcast were:

• A new treatment that improves cough in individuals with pulmonary fibrosis
• Respiratory experts warn that AI tools could mislead patients and urge caution
• New research that spotlights the burden of respiratory disease in Asia

This broadcast also featured:

• Paper in focus: Poorer health and reduced quality of life experienced by female pulmonologists - related to their professional activities;
• Guest interview: Leading experts Dr Hitasha Rupani and Dr Kjell Håkansson provide a deep dive into asthma. Hitasha and Kjell have both recently published major papers on the topic of asthma remission - among the hottest topics in this specialist area.

Hosted by European Respiratory Journal Chief Editor Prof. James Chalmers, Respiratory News Live presents respiratory news from the past 30 days. Broadcasts will cover the hottest topics, the newest therapies, breaking news, and the most significant scientific developments. It will also highlight any developments on the horizon. Each event will also feature a live audience Q&A. Attendance at the event is free, but registration in advance is required.

Target audience:

• Pulmonologists
• Clinicians
• Respiratory researchers
• Basic and translational scientists
• Epidemiologists
• Thoracic surgeons
• Thoracic oncologists
• Respiratory paediatricians
• Allied healthcare professionals
• Patient representatives

About the event host: Prof. James Chalmers

Prof. James Chalmers MBChB, PhD is the Rhodes Chair of Experimental Therapeutics at the University of Oxford, and serves as a clinician-scientist in respiratory medicine, and an honorary consultant.

 

Prof. Chalmers is also Chief Editor of the European Respiratory Journal. His clinical work focuses on difficult respiratory infections and bronchiectasis, and his research portfolio encompasses immunology, microbiome, mucociliary clearance, and translational experimental medicine in lung disease, including bronchiectasis, COPD and acute respiratory infections.

 

He has published more than 500 peer-reviewed manuscripts, and chaired major European respiratory guideline panels on topics such as bronchiectasis, COPD, and COVID-19. He also chairs the EMBARC European Bronchiectasis Network, leads international EMBARC studies and trials, and is a lead author on key bronchiectasis publications.